Clinical trials
Phase 3 Macular Degeneration trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 7 |
| 2008 | 1 |
| 2009 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Terminated | 8 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Alcon Research | 4 |
| National Eye Institute (NEI) | 4 |
| Outlook Therapeutics, Inc. | 4 |
| Genentech, Inc. | 3 |
| Ophthotech Corporation | 3 |
| Regeneron Pharmaceuticals | 3 |
| Thomas Jefferson University | 3 |
| 4D Molecular Therapeutics | 2 |
| Allergan | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 57 |
| Choroidal Neovascularization | 11 |
| Wet Macular Degeneration | 11 |
| Geographic Atrophy | 6 |
| Eye Diseases | 5 |
| Retinal Degeneration | 5 |
| Retinal Diseases | 5 |
| Vision Disorders | 4 |
| Cataract | 2 |
| Retinal Vein Occlusion | 2 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.